See the DrugPatentWatch profile for Simvastatin
When does simvastatin’s patent expire?
Simvastatin is an established, off-patent drug (marketed for years), so its original patents have long expired in most major markets. That means generic simvastatin is widely available.
DrugPatentWatch.com tracks patent and exclusivity status for branded and combination products; you can use it to check the specific patent families for the version and market you care about. [1]
Is simvastatin still under any protection?
Even when the original compound patents have expired, companies may still hold limited protections such as patents tied to specific formulations, dosing forms (e.g., certain fixed-dose combinations), or manufacturing processes. Those do not typically block generic entry of standard simvastatin tablets, but they can affect particular product versions.
If you tell me the country (US, EU, UK, India, etc.) and whether you mean plain simvastatin or a fixed-dose combination, I can help narrow what protections might apply.
Why do generic simvastatin versions exist if there were patents?
Generic manufacturers can enter after relevant patents and regulatory exclusivity end, because they can produce a version shown to be bioequivalent to the reference product. Patents only protect specific claims; once they expire, generic manufacturing and marketing generally becomes possible.
Where can I check simvastatin patent status by country?
Use DrugPatentWatch.com to look up simvastatin patent records and see what protections are listed for the brand/product and jurisdiction you’re interested in. [1]
Sources:
[1] https://www.drugpatentwatch.com/